Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1304528

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1304528

Global Respiratory Monitoring Devices Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The Global Respiratory Monitoring Devices Market reached US$ 4.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 9.3 billion by 2030. The global respiratory monitoring devices market is expected to exhibit a CAGR of 9.3% during the forecast period 2023-2030.

A Respiratory Monitoring Device Evaluates the airways' regular operation and oxygen delivery. Several respiratory tests are being developed to evaluate the efficacy of the lungs in exchanging breathing gases and finding respiratory tract blockages. Sales of respiratory monitoring devices are used to augment the respiratory monitoring device market.

Respiratory Monitoring Devices track parameters related to breathing, which help diagnose respiratory illnesses. The growing air pollution, cases of respiratory disorders, geriatric population, and market developments promote the global respiratory monitoring devices market.

Market Dynamics

Rise in Geriatric Population

The rise in the geriatric population is one of the significant drivers that drive the market growth in the forecast period. The rise in the population of older people led to increasing the respiratory monitoring devices since the immune system of a person gets weak at this age where the requirement of respiratory monitoring devices is essential to use, which indeed helps the market to grow during the forecast period.

For instance, according to the article published in NCBI, being a smoker, an alcoholic, polypharmacy, and the presence of additional co-morbidities were factors that affected the treatment results of older adults infected with respiratory diseases which indeed needed respiratory monitoring devices that helps the market to grow in future.

Increasing Healthcare Expenditure

The respiratory care devices market is driven by rising healthcare expenditures in developed and developing nations. This is due to those nations' governments are spending in enhancing the quality of healthcare facilities. Furthermore, factors such as rising healthcare spending per capita in emerging nations, mainly due to increased government initiatives, will likely boost treatment affordability and accessibility, aiding market expansion.

For instance, according to the Forum of International Respiratory Societies, Asthma and COPD cause around 489,000 fatalities per year, or more than 1300 deaths per day, and impact more than 200 million people worldwide, with 65 million having moderate or severe airway disease. As a result, the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease and asthma is propelling the market forward.

Lack of Awareness of Respiratory Monitoring Devices

One of the restraints to market growth is a lack of awareness of respiratory monitoring devices. The lack of information and utilization of the devices will lead to a reduction in market growth.

Many conditions affect the market, including individuals unaware of these devices and failing to recognize the early signs and symptoms of respiratory disorders or the need to monitor their respiratory health. This causes delays in seeking medical attention, leading to delayed diagnosis and treatment.

COVID-19 Impact Analysis

With the growth of COVID-19 cases worldwide, the need for respiratory monitoring devices, including pulse oximeters, ventilators, and spirometers, has skyrocketed. These devices are critical for monitoring oxygen saturation levels, lung function, and respiratory assistance to patients suffering from acute respiratory distress. Supply chain issues have also been a factor, with growing demand for respiratory monitoring equipment putting strain on the worldwide supply chain.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global respiratory monitoring devices market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global respiratory monitoring devices market growth over the forecast period.

Segment Analysis

The Global Respiratory Monitoring Devices Market is segmented based on product, end user and region.

The Peak Flow Meters Product Segment Accounted for Approximately 24.9% of the Respiratory Monitoring Devices Market Share

The peak flow meter devices are used to measure the rate of breathing. Peak flow meters that are lightweight, simple to handle and transport, and remotely accessible are in high demand. For instance, On April 18 2023, Tenovi has introduced a cellular FDA-cleared remote peak flow meter (PFM) for advanced remote physiological monitoring of asthmatic patients.

When combined with Tenovi's cellular gateway, the device allows patients with asthma to transmit peak expiratory flow rate (PEF) and 1-second forced expiratory volume (fev1) readings instantly to clinicians. Asthma is a chronic respiratory condition that affects millions of people worldwide, and effective monitoring of asthmatic symptoms is essential for proper management.

Geographical Analysis

North America Accounted for Approximately 39.5% of the Market Share Owing to the Strong Presence of Major Players.

North America is estimated to hold about 39.5% of the total market share throughout the forecast period. The dominating market, such as the United States, is distinguished by increased healthcare expenditures, robust healthcare infrastructure, and enhanced access to healthcare services.

The average per capita healthcare spending in the United States was $40,624 in 2022. Furthermore, rising public awareness of the many sophisticated respiratory monitoring equipment has aided North American respiratory monitoring devices' growth.

Competitive Landscape

The major global players in respiratory monitoring devices include: GE Healthcare, Smith & Nephew, Vyaire (CareFusion Corporation), Masimo Corporation, Medtronic, MGC Diagnostics Corporation, COSMEDN, Nihon Kohden Corporation, Philips Healthcare, and Novelda AS, among others.

Why Purchase the Report?

  • To visualize the Global Respiratory Monitoring Devices Market segmentation based on product, end user and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of respiratory monitoring devices market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Respiratory Monitoring Devices Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD6134

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by End User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Respiratory Diseases
      • 4.1.1.2. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Longer Duration of Approval Process
    • 4.1.3. Opportunity
      • 4.1.3.1. Investment by key players in emerging markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Spirometer *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Peak Flow Meters
  • 7.4. Sleep Test Devices
  • 7.5. Gas Analyzers
  • 7.6. Pulse Oximeters
  • 7.7. Capnography
  • 7.8. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgery Centers
  • 8.4. Homecare
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Spain
      • 9.3.5.5. Italy
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan

Australia

      • 9.5.5.4. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. GE Healthcare *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Smith & Nephew
  • 11.3. Vyaire (Carefusion Corporation)
  • 11.4. Masimo Corporation
  • 11.5. Medtronic plc
  • 11.6. MGC Diagnostics Corporation
  • 11.7. COSMED
  • 11.8. Nihon Kohden Corporation
  • 11.9. Philips Healthcare
  • 11.10. Novelda AS

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!